Biodexa Pharmaceuticals Plc (BDRX)
NASDAQ: BDRX · Real-Time Price · USD
2.490
-0.100 (-3.86%)
Jul 10, 2026, 4:00 PM EDT - Market closed
Biodexa Pharmaceuticals Employees
Biodexa Pharmaceuticals had 11 employees as of December 31, 2025. The number of employees decreased by 2 or -15.38% compared to the previous year.
Employees
11
Change (1Y)
-2
Growth (1Y)
-15.38%
Revenue / Employee
n/a
Profits / Employee
-$781,109
Market Cap
2.06M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 11 | -2 | -15.38% |
| Dec 31, 2024 | 13 | -8 | -38.10% |
| Dec 31, 2023 | 21 | -6 | -22.22% |
| Dec 31, 2022 | 27 | 7 | 35.00% |
| Dec 31, 2021 | 20 | 2 | 11.11% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Valion Bio | 52 |
| Jaguar Health | 47 |
| Calidi Biotherapeutics | 29 |
| VivoSim Labs | 14 |
| Azitra | 13 |
| CDT Equity | 4 |
| GRI Bio | 4 |
| Oragenics | 3 |
BDRX News
- 12 days ago - Result of Annual General Meeting - GlobeNewsWire
- 13 days ago - Biodexa Pharmaceuticals announces pricing of $3.5M registered offering - TheFly
- 13 days ago - Biodexa Announces Pricing of $3.5 Million Registered Direct Offering & Concurrent Private Placement of Pre-Funded Warrants and Warrants - GlobeNewsWire
- 13 days ago - Biodexa Pharmaceuticals receives Health Canada approval for Serenta trial - TheFly
- 14 days ago - Approval from Health Canada to expand Serenta Registrational Phase 3 trial in FAP and Update on Serenta Progress - GlobeNewsWire
- 25 days ago - Postponement and Re-scheduling of Annual General Meeting - GlobeNewsWire
- 2 months ago - Biodexa issues letter to Shareholders - GlobeNewsWire
- 3 months ago - Biodexa Pharmaceuticals PLC-ADR trading halted, news pending - TheFly